c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 901–1,000 of 1,006
NMDA Receptor and Its Emerging Role in Cancer
Gallo, S., Vitacolonna, A., & Crepaldi, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032540 · Cited by 53
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 62
Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
Fogal, V., Babic, I., Chao, Y., Pastorino, S., Mukthavaram, R., Jiang, P., Cho, Y.-J., Pingle, S. C., Crawford, J. R., Piccioni, D. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2708 · Cited by 45
Li, Z., Wang, Y., Wu, H., Zhang, L., Yang, P., & Li, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2105 · Cited by 50
Chandran, P. A., Keller, A., Weinmann, L., Seida, A. A., Braun, M., Andreev, K., Fischer, B., Horn, E., Schwinn, S., Junker, M., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-025r · Cited by 52
Research into cancer metabolomics: Towards a clinical metamorphosis
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45
CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function
Masamha, C. P., Xia, Z., Peart, N., Collum, S., Li, W., Wagner, E. J., & Shyu, A.-B. (2016) · RNA · doi:10.1261/rna.055939.116 · Cited by 44
Askou, A. L., Alsing, S., Holmgaard, A., Bek, T., & Corydon, T. J. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13407 · Cited by 49
MicroRNAs in Oncogenesis and Tumor Suppression
Barbato, S., Solaini, G., & Fabbri, M. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.05.001 · Cited by 48
Mazzoccoli, L., Robaina, M. C., Apa, A. G., Bonamino, M., Pinto, L. W., Queiroga, E., Bacchi, C. E., & Klumb, C. E. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2575-3 · Cited by 48
Functional Role of microRNA-23b-3p in Cancer Biology
Grossi, I., Salvi, A., Baiocchi, G. L., Portolani, N., & Petro, G. D. (2018) · MicroRNA · doi:10.2174/2211536607666180629155025 · Cited by 50
Ramirez‐Peña, E., Arnold, J. M., Shivakumar, V., Joseph, R., Vijay, G. V., den Hollander, P., Bhangre, N., Allegakoen, P., Prasad, R., Conley, Z. C., et al. (2019) · Cancers · doi:10.3390/cancers11101610 · Cited by 46
Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
Sarlak, S., Lalou, C., Amoêdo, N. D., & Rossignol, R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.09.001 · Cited by 55
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 49
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Cardoso, H. J., Carvalho, T. M. A., Fonseca, L. R. S., Figueira, M. I., Vaz, C. V., & Socorro, S. (2020) · Medicinal Research Reviews · doi:10.1002/med.21766 · Cited by 54
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Arora, A., Singh, S. P., Bhatt, A. N., Pandey, S., Sandhir, R., & Dwarakanath, B. S. R. (2015) · Translational Oncogenomics · doi:10.4137/tog.s29652 · Cited by 44
Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis
Han, J., Zhang, Y., Xu, J., Zhang, T., Wang, H., Wang, Z., Jiang, Y., Zhou, L., Yang, M., Hua, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.008 · Cited by 47
Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
Chhipa, A. S., & Patel, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119694 · Cited by 46
Therapeutic potential of NR4A1 in cancer: Focus on metabolism
Deng, S., Chen, B., Huo, J., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.972984 · Cited by 46
Liu, J., Song, Y., Wang, Y., Han, M., Wang, C., & Yan, F. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c09978 · Cited by 44
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 49
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
DeLaBarre, B., Hurov, J., Cianchetta, G., Murray, S., & Dang, L. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.007 · Cited by 50
Diphenylarsinic Acid Promotes Degradation of Glutaminase C by Mitochondrial Lon Protease
Kita, K., Suzuki, T., & Ochi, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362699 · Cited by 45
Self-citationSánchez‐Martínez, D., Krzywińska, E., Rathore, M. G., Saumet, A., Cornillon, A., López-Royuela, N., Martínez‐Lostao, L., Ramírez-Labrada, A., Lu, Z., Rossi, J., et al. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.01.003 · Cited by 50
MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation.
Li, J., Wan, X., Wu, Q., Li, T., Huang, W., Huang, S., Wu, D., & Li, Y. (2015) · PubMed Central · Cited by 50
Xiao, S., Yang, Z. H., Qiu, X., Lv, R., Liu, J., Wu, M., Liao, Y., & Liu, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.10357 · Cited by 44
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 50
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
Nakatsu, Y., Yamamotoya, T., Ueda, K., Ono, H., Inoue, M.-K., Matsunaga, Y., Kushiyama, A., Sakoda, H., Fujishiro, M., Matsubara, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.043 · Cited by 44
Molecular marks for epigenetic identification of developmental and cancer stem cells
Patra, S. K., Deb, M., & Patra, A. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0016-0 · Cited by 46
Kokontis, J. M., Lin, H., Jiang, S. S., Lin, C., Fukuchi, J., Hiipakka, R. A., Chung, C., Chan, T.-M., Liao, S., Chang, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109170 · Cited by 48
Transcriptional control of DNA replication licensing by Myc
Valovka, T., Schönfeld, M., Raffeiner, P., Breuker, K., Dunzendorfer-Matt, T., Hartl, M., & Bister, K. (2013) · Scientific Reports · doi:10.1038/srep03444 · Cited by 42
Sanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 46
Cetinbas, N. M., Sudderth, J., Harris, R. C., Cebeci, A., Negri, G. L., Yılmaz, Ö. H., DeBerardinis, R. J., & Sorensen, P. H. (2016) · Scientific Reports · doi:10.1038/srep32606 · Cited by 43
The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
Nagdas, S., & Kashatus, D. F. (2017) · Antioxidants · doi:10.3390/antiox6020033 · Cited by 49
Zhang, H., Wang, L., Hou, Z., Ma, H., Mamtimin, B., Hasim, A., & Sheyhidin, I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.060 · Cited by 45
Celastrol mediates Th17 and Treg cell generation via metabolic signaling
Zhang, J., Shan, J., Chen, X., Li, S., Long, D., & Li, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.163 · Cited by 44
NMR-Based Metabolomics in Metal-Based Drug Research
Castro, F. D., Benedetti, M., Coco, L. D., & Fanizzi, F. P. (2019) · Molecules · doi:10.3390/molecules24122240 · Cited by 47
Self‐Delivery Nanomedicine for Glutamine‐Starvation Enhanced Photodynamic Tumor Therapy
Zhao, L., Chen, S., Zheng, R., Kong, R., Rao, X., Chen, A., Cheng, H. B., Zhang, D., Li, S., & Yu, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102038 · Cited by 45
Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy
Xu, Y., Yu, Z., Fu, H., Guo, Y., Hu, P., & Shi, J. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c00111 · Cited by 46
Glutamine metabolism in cancers: Targeting the oxidative homeostasis
Gong, T., Zheng, C., Ou, X., Zheng, J., Yu, J., Chen, S., Duan, Y., & Liu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.994672 · Cited by 40
MYC—an emerging player in mitochondrial diseases
Purhonen, J., Klefström, J. T., & Kallijärvi, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1257651 · Cited by 45
A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines
Sugimoto, K., Suzuki, H. I., Fujimura, T., Ono, A., Kaga, N., Isobe, Y., Sasaki, M., Taka, H., Miyazono, K., & Komatsu, N. (2015) · Cancer Science · doi:10.1111/cas.12807 · Cited by 48
Briehl, M. M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.002 · Cited by 44
Sloan, E. J., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910377489 · Cited by 41
Hyaluronan Synthases Posttranslational Regulation in Cancer
Vigetti, D., & Passi, A. G. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00004-6 · Cited by 52
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 44
Self-citationde la Oliva, A. R. L., Campos-Sandoval, J. A., Gómez-García, M. C., Cardona, C., Martín‐Rufián, M., Sialana, F. J., Castilla, L., Bae, N., Lobo, C., Peñalver, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58264-4 · Cited by 44
The role of the glutamine transporter ASCT2 in antineoplastic therapy
Teixeira, E., Silva, C., & Martel, F. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04218-6 · Cited by 51
USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression
Tu, R., Kang, W., Yang, M., Wang, L., Bao, Q., Chen, Z., Dong, Y., Wang, J., Jiang, J., Liu, H., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02031-w · Cited by 45
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 46
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
Yu, Z., Zhou, X., & Wang, X. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0917 · Cited by 45
Gorgoglione, R., Impedovo, V., Riley, C. L., Fratantonio, D., Tiziani, S., Palmieri, L., Dolce, V., & Fiermonte, G. (2022) · Cancers · doi:10.3390/cancers14010245 · Cited by 48
Oncogenes strike a balance between cellular growth and homeostasis
Qiu, B., & Simon, M. C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.005 · Cited by 50
Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5
Tago, K., Funakoshi‐Tago, M., Itoh, H., Furukawa, Y., Kikuchi, J., Kato, T., Suzuki, K., & Yanagisawa, K. (2014) · Oncogene · doi:10.1038/onc.2013.561 · Cited by 44
The Might of MicroRNA in Mitochondria
Latronico, M. V. G., & Condorelli, G. (2012) · Circulation Research · doi:10.1161/circresaha.112.271312 · Cited by 41
Cao, T.-T., Lin, S.-H., Fu, L., Tang, Z., Che, C., Zhang, L.-Y., Ming, X.-Y., Liu, T.-F., Tang, X., Tan, B.-B., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw119 · Cited by 42
MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
Chen, P., Guo, X., Zhang, L., Zhang, W., Zhou, Q. S., Tian, Z., Zheng, Y., Liao, Q., Wang, H., Li, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14123 · Cited by 42
The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies
Filip, D., & Mráz, M. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1675877 · Cited by 48
Fan, Y., Xue, H., Li, Z., Huo, M., Gao, H., & Guan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345522 · Cited by 40
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Shuvalov, O. Y., Kirdeeva, Y., Daks, A. A., Fedorova, O., Parfenyev, S. E., Simon, H., & Barlev, N. A. (2023) · Antioxidants · doi:10.3390/antiox12112012 · Cited by 51
Trejo‐Solís, C., Silva‐Adaya, D., Serrano-García, N., Magaña-Maldonado, R., Jiménez‐Farfán, D., Ferreira-Guerrero, E., Cruz-Salgado, A., & Castillo‐Rodríguez, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417633 · Cited by 50
USP2a alters chemotherapeutic response by modulating redox
Benassi, B., Marani, M., Loda, M. F., & Blandino, G. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.289 · Cited by 41
Li, Y., Li, X., Li, X., Zhong, Y., Ji, Y., Yu, D., Zhang, M., Wen, J., Zhang, H., Goscinski, M. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10782 · Cited by 51
RetractedAlteration of cellular metabolism in cancer cells and its therapeutic prospects
Biswal, B. N., Das, S., Das, B., & Rath, R. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_60_17 · Cited by 62
Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
Matés, J. M., Campos-Sandoval, J. A., Santos-Jiménez, J. D. L., Segura, J. A., Alonso, F. J., & Márquez, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190416165004 · Cited by 42
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 45
Hsu, Y., Chen, H., Yuan, S., Yu, S., Lin, C., Wu, G., Yang, P., & Li, K.-C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-106 · Cited by 46
Guo, F., Estévez‐Vázquez, O., Benedé‐Ubieto, R., Maya‐Miles, D., Zheng, K., Gallego‐Durán, R., Rojas, Á., Ampuero, J., Romero‐Gómez, M., Kaye, P., et al. (2021) · Cancers · doi:10.3390/cancers14010192 · Cited by 41
Polónia, B. R. G., Xavier, C. P. R., Kopecka, J., Riganti, C., & Vasconcelos, M. H. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.05.001 · Cited by 40
Amino acid metabolism in tumor: New shine in the fog?
Qiu, H., Shao, N., Liu, J., Zhao, J.-J., Chen, C., Li, Q., He, Z., Zhao, X., & Xu, L. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.011 · Cited by 40
Gore, M., Kabekkodu, S. P., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189292 · Cited by 50
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 43
Lodi, A., & Ronen, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026155 · Cited by 42
The role of microRNA in castration-resistant prostate cancer
Thieu, W., Tilki, D., White, R. D., & Evans, C. P. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.11.004 · Cited by 41
Saumet, A., Vetter, G., Bouttier, M., Antoine, E., Roubert, C., Orsetti, B., Theillet, C. G., & Lecellier, C. (2012) · Molecular BioSystems · doi:10.1039/c2mb25298h · Cited by 40
Glutaminolysis and carcinogenesis of oral squamous cell carcinoma
Cetindis, M., Biegner, T., Munz, A., Teriete, P., Reinert, S., & Grimm, M. R. (2015) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-015-3543-7 · Cited by 41
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 41
Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome
Budczies, J., & Denkert, C. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_7 · Cited by 41
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
Hur, W., Ryu, J. Y., Kim, H. U., Hong, S. W., Lee, E. B., Lee, S. Y., & Yoon, S. K. (2017) · Scientific Reports · doi:10.1038/srep45557 · Cited by 41
miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase
Luan, W., Zhou, Z., Zhu, Y., Xia, Y. F., Wang, J., & Xu, B. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.152 · Cited by 39
Sequencing and characterization of lncRNAs in the breast muscle of Gushi and Arbor Acres chickens
Ren, T., Li, Z., Zhou, Y., Liu, X., Han, R., Wang, Y., Yan, F., Sun, G., Li, H., & Kang, X. (2018) · Genome · doi:10.1139/gen-2017-0114 · Cited by 45
Enzymes in Metabolic Anticancer Therapy
Maggi, M., & Scotti, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7709-9_9 · Cited by 44
Colorectal cancer: The epigenetic role of microbiome
Sabit, H., Çevik, E., & Tombuloğlu, H. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i22.3683 · Cited by 42
Shi, X., Xi, B., Jasbi, P., Turner, C., Jin, Y., & Gu, H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01767 · Cited by 42
14-3-3 σ: A potential biomolecule for cancer therapy
Huang, Y., Yang, M., & Huang, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.009 · Cited by 42
Defining the Molecular Basis of Tumor Metabolism: a Continuing Challenge Since Warburg’s Discovery
de Souza, A. C. S., Justo, G. Z., de Araújo, D. R., & Cavagis, A. D. M. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335792 · Cited by 43
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 42
Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion
Caino, M., & Altieri, D. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1084448 · Cited by 36
p32 (C1QBP) and Cancer Cell Metabolism: Is the Warburg Effect a Lot of Hot Air?
Dang, C. V. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01661-09 · Cited by 42
Self-citationMetabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 42
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
Venkatraman, S., Balasubramanian, B., Thuwajit, C., Meller, J., Tohtong, R., & Chutipongtanate, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324045 · Cited by 47
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Trejo‐Solís, C., Castillo‐Rodríguez, R. A., Serrano-García, N., Silva‐Adaya, D., Vargas-Cruz, S., Chávez-Cortéz, E. G., Gallardo‐Pérez, J. C., Zavala-Vega, S., Cruz-Salgado, A., & Magaña-Maldonado, R. (2024) · Metabolites · doi:10.3390/metabo14050249 · Cited by 42
Sharma, B. K., Kolhe, R. B., Black, S. M., Keller, J. R., Mivechi, N. F., & Ande, S. (2015) · The FASEB Journal · doi:10.1096/fj.15-277749 · Cited by 40
MicroRNAs as putative mediators of treatment response in prostate cancer
O’Kelly, F., Marignol, L. H., Meunier, A., Lynch, T. H., Perry, A. S., & Hollywood, D. P. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.104 · Cited by 41
Garbett, K. A., Vereczkei, A., Kalman, J. L., Wang, L., Korade, Ž., Shelton, R. C., & Mirnics, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.14 · Cited by 37
Alternative fuel—another role for p53 in the regulation of metabolism
Vousden, K. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002656107 · Cited by 38
Integrating T cell metabolism in cancer immunotherapy
Dugnani, E., Pasquale, V., Bordignon, C., Canu, A., Piemonti, L., & Monti, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.039 · Cited by 38
Ye, Y., Wu, Y., & Wang, J. (2018) · Cancer Management and Research · doi:10.2147/cmar.s166711 · Cited by 38
Emerging Role of microRNAs in Dementia
Ramakrishna, S., & Muddashetty, R. S. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.046 · Cited by 43
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.